$2.8M sweet spot round size
Most of their 162 investments are in rounds between $18M and $52M
2020
Avalyn Pharma Inc. raised $175M on September 27, 2023
Investors: Surveyor Capital, Vida Ventures, LLC, Novo Holdings, Wellington Management, RiverVest Venture Partners, Perceptive Advisors and S.R. One Ltd
Undisclosed raised $210M on September 6, 2023
Investors: GV, Atlas Venture, RA Capital Management, L.P., Lightstone Ventures and S.R. One Ltd
Fore Biotherapeutics raised $75M on August 23, 2023
Investors: Medicxi, OrbiMed Advisors, 3B Future Health Fund, Wellington Management, HBM Partners AG and S.R. One Ltd
PULMOCIDE LIMITED raised $52M on December 6, 2022
Investors: 旭化成ファーマ(株), Vivo Capital, JEITO, F-Prime Capital Partners, Longwood Fund, IP Group plc, SV Life Sciences and S.R. One Ltd
Rezo Therapeutics raised $78M on November 17, 2022
Investors: UCSF Foundation Investment Company, Hawktail, SV Angel, Andreessen Horowitz, Norwest Venture Partners, Liquid 2 Ventures and S.R. One Ltd
Odyssey Therapeutics raised $168M on October 13, 2022
Investors: Walleye Capital, SVB Securities, Logos Global Management, LP, General Catalyst, OrbiMed Advisors, Woodline Partners LP, GreatPoint Ventures, T. Rowe Price and S.R. One Ltd
Undisclosed raised $125M on September 12, 2022
Investors: SV Life Sciences, Lightstone Ventures, RA Capital Management, L.P., Atlas Venture and S.R. One Ltd
MiroBio Ltd raised $97M on June 29, 2022
Investors: Monograph Capital, Oxford Sciences Innovation, OrbiMed Advisors, Advent Life Sciences, Samsara BioCapital, Medicxi and S.R. One Ltd
Ancora Biotech raised $60M on June 18, 2022
Investors: Lightspeed Venture Partners and S.R. One Ltd
Dren Bio, Inc. raised $65M on June 14, 2022
Investors: HBM Partners AG, Revelation Partners, Mission BioCapital and S.R. One Ltd